glp 1 approved for mash 🚨 Breaking medical news! 🚨 The FDA has just Wegovy (semaglutide) as the first GLP-1 medication — a serious form of fatty liver disease. ✓ Indicated for adults with Wegovy Gets F.D.A. Approval for

Persistent or severe gastrointestinal symptoms while on GLP-1 therapy, such as severe nausea, vomiting, diarrhea, or severe abdominal pain, should prompt immediate medical evaluation

Perfect for professional athletes, fitness enthusiasts, and anyone preparing for or recovering from demanding physical activity, it supports rapid rehydration, faster muscle recovery, and sustained energy levels

For anyone who experiences this side effect, it can be a frustrating and uncomfortable experience

Contact us to learn more

TZDs uniquely target insulin resistance, which is a core physiologic defect in T2D, and significantly improve glucose control

facility with tracking